UNITED STRENGTH (02337) released its annual performance, with a net loss of 2.374 million yuan attributable to shareholders, a year-on-year change from profit to loss.
Zhong Cheng Energy (02337) released its performance for the year ending December 31, 2025. The group achieved revenue of RMB 6.164 billion, a decrease of 20.21% compared to the previous year; the company's equity shareholders' loss was RMB 2.374 million, compared to a profit of RMB 67.791 million in the same period last year; loss per share was RMB 0.01.
UNITED STRENGTH (02337) released its annual performance for the year ending December 31, 2025. The group achieved revenue of 6.164 billion yuan, a decrease of 20.21% year-on-year; the net loss attributable to equity shareholders of the company was 2.374 million yuan, compared to a profit of 67.791 million yuan in the same period last year; the loss per share was 0.01 yuan.
The announcement stated that the decrease in revenue was mainly due to the decrease in sales volume and average selling price of the company's wholesale and retail petroleum products in 2025.
Related Articles

SHENGUAN HLDGS (00829) announced the financial performance for 2025. The net loss attributable to the owners of the company was 69.773 million yuan, a decrease from a profit in the same period last year.

GUANGDONG INV (00270): Wang Min appointed as Acting Chairman of the Board of Directors and Acting Chairman of the Nomination Committee.

ILUVATAR COREX(09903) 2025 performance report released: Revenue from the reasoning series increased by 238.2% year-on-year, with both training and competition tracks making strong efforts.
SHENGUAN HLDGS (00829) announced the financial performance for 2025. The net loss attributable to the owners of the company was 69.773 million yuan, a decrease from a profit in the same period last year.

GUANGDONG INV (00270): Wang Min appointed as Acting Chairman of the Board of Directors and Acting Chairman of the Nomination Committee.

ILUVATAR COREX(09903) 2025 performance report released: Revenue from the reasoning series increased by 238.2% year-on-year, with both training and competition tracks making strong efforts.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


